Today Dr. Maria Luisa Nolli has been appointed to the board of EuropaBio, the European Association for Bioindustries, on behalf of Assobiotec, founding member of EuropaBio.

MolMed leads a consortium which awarded a € 1.4 million grant by Regione Lombardia for the optimisation of TK therapy manufacturing process.
MolMed S.p.A., a medical biotechnology company focused on the development of novel anticancer therapeutics, announces that the company is leader of a consortium that has been awarded a grant of € 1.4 million by Regione Lombardia for a € 2.2 million R&D project aimed at developing an innovative, automated manufacturing process for its cell-based therapy TK, that is currently in Phase III for high-risk leukaemias.

areta international was selected with the project “Development of innovative biodrugs based on cells fot the treatment of niche pathologies and patient specific” for Italia degli Innovatori, the initiative launched by the Italian Minister of Innovation Renato Brunetta and the General Commissioner Beniamino Quinteri.

The volume dedicated to the city of Milan of the series entitled  “The women protagonist”, by Carlo Enrico Bazzani, was presented yesterday in Milan, at the Hall of Palazzo Castiglioni Orlando (Corso Venezia 47/49).
Maria Luisa Nolli, Chief Executive Officer of areta international is among the 100 “women protagonist” of the city of Milan. A recognition of a path initiated ten years ago when the professionalism, courage, passion and tenacity to focus on advanced research in the field of innovative therapies have transformed the initial idea into business reality.